Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsector:
Small molecules
Indication:
Neoplasms / cancer / oncology
Products
In development: 7
Description:
MOMA Therapeutics is a clinical-stage, next-generation precision medicine company focused on targeting highly dynamic proteins that underlie human disease via a small molecule approach, utilizing its proprietary KNOMATIC platform. The company's pipeline includes MOMA-313, a novel, highly potent and selective oral polymerase theta helicase inhibitor initially being developed in combination with a PARP inhibitor for patients with solid tumors harboring alterations in certain DNA repair genes,...
